A review of respiratory syncytial virus epidemiology among children: linking effective prevention to vulnerable populations

D Daniels�- Journal of the Pediatric Infectious Diseases Society, 2024 - academic.oup.com
Respiratory syncytial virus (RSV) is the greatest contributor to lower respiratory tract
infections (LRTI) in children less than 5 years of age and the leading cause for infant�…

The full value of immunisation against respiratory syncytial virus for infants younger than 1 year: effects beyond prevention of acute respiratory illness

DR Feikin, RA Karron, SK Saha, E Sparrow…�- The Lancet Infectious�…, 2024 - thelancet.com
Respiratory syncytial virus (RSV) is a leading cause of severe respiratory illness and death
among children worldwide, particularly in children younger than 6 months and in low�…

[HTML][HTML] Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus–Associated Hospitalization Among Infants Entering Their First�…

HL Moline�- MMWR. Morbidity and mortality weekly report, 2024 - cdc.gov
Respiratory syncytial virus (RSV) is the leading cause of hospitalization among infants in the
United States. In August 2023, CDC's Advisory Committee on Immunization Practices�…

Nonadjuvanted bivalent respiratory syncytial virus vaccination and perinatal outcomes

M Son, LE Riley, AP Staniczenko, J Cron…�- JAMA Network�…, 2024 - jamanetwork.com
Importance A nonadjuvanted bivalent respiratory syncytial virus (RSV) prefusion F (RSVpreF
[Pfizer]) protein subunit vaccine was newly approved and recommended for pregnant�…

Respiratory syncytial virus-associated hospitalizations among children< 5 years old: 2016 to 2020

AT Curns, B Rha, JY Lively, LC Sahni, JA Englund…�- …, 2024 - publications.aap.org
BACKGROUND Respiratory syncytial virus (RSV) is the leading cause of hospitalization in
US infants. Accurate estimates of severe RSV disease inform policy decisions for RSV�…

Risk Analysis of Respiratory Syncytial Virus Among Infants in the United States by Birth Month

JR Gantenberg, R van Aalst…�- Journal of the�…, 2024 - academic.oup.com
Background Respiratory syncytial virus (RSV) is a major cause of morbidity and mortality
among US infants. A child's calendar birth month determines their age at first exposure (s) to�…

Infectious Disease Updates for Primary Care

DJ McCulloch, PS Pottinger�- Medical Clinics, 2024 - medical.theclinics.com
The last year has brought exciting developments in the prevention and treatment of
infectious diseases for primary care: new vaccines to prevent respiratory syncytial virus�…

Nirsevimab: a review

H Balbi�- Pediatric Allergy, Immunology, and Pulmonology, 2024 - liebertpub.com
Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infections in
people of all ages and is the leading cause of hospitalization among infants in the United�…

Multi-faceted analysis and prediction for the outbreak of pediatric respiratory syncytial virus

C Yang, J Gao, L Glass, A Cross…�- Journal of the American�…, 2024 - academic.oup.com
Objectives Respiratory syncytial virus (RSV) is a significant cause of pediatric
hospitalizations. This article aims to utilize multisource data and leverage the tensor�…

Geographic Progression of Infant Respiratory Syncytial Virus Associated Bronchiolitis Across the United States Before and Since the Onset of COVID‐19: Results�…

AZ Blatt, M Suh, EB Walter Jr, CT Wood…�- Influenza and Other�…, 2024 - Wiley Online Library
Background Respiratory syncytial virus (RSV) is a substantial cause of infant morbidity and
mortality due to seasonal peaks of bronchiolitis across the United States. Clinical and viral�…